• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $CDRE

    Cadre Holdings Inc.

    Subscribe to $CDRE
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings, Inc. manufactures and distributes safety and survivability equipment that provides protection to users in hazardous or life-threatening situations. It primarily provides body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brands; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective and law enforcement equipment. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, and various foreign government agencies internationally. The company was incorporated in 2012 and is headquartered in Jacksonville, Florida.

    IPO Year: 2021

    Exchange: NYSE

    Website: cadre-holdings.com

    Recent Analyst Ratings for Cadre Holdings Inc.

    DatePrice TargetRatingAnalyst
    8/13/2025$26.00Neutral → Underperform
    BofA Securities
    6/13/2025$38.00Buy → Neutral
    BofA Securities
    2/21/2024$32.00 → $38.00Buy
    ROTH MKM
    1/22/2024Outperform → Mkt Perform
    Raymond James
    9/6/2022$30.00Buy
    BofA Securities
    8/31/2022$32.00Buy
    Jefferies
    3/11/2022$25.00 → $27.00Outperform
    Raymond James
    11/29/2021$24.00Buy
    Lake Street
    11/29/2021$23.00Overweight
    Stephens
    11/29/2021$20.00Hold
    Stifel
    See more ratings

    Cadre Holdings Inc. Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cadre Holdings Reports Second Quarter 2025 Financial Results

    Increased Quarterly Net Sales 9% and Gross Profit 10% Year-Over-Year Continued Strong Demand Trends for Mission Critical Safety Equipment Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three and six months ended June 30, 2025. Net sales of $157.1 million for the second quarter; net sales of $287.2 million for the six months ended June 30, 2025. Gross profit margin of 40.9% for the second quarter; gross profit margin of 41.9% for the six months

    8/5/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Announces Second Quarter 2025 Earnings and Conference Call Information

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the second quarter that ended on June 30, 2025, on Tuesday, August 5, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, August 6, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To partici

    7/23/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Declares Quarterly Dividend of $0.095 Per Share

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on August 15, 2025 to shareholders of record as of the close of business on the record date of August 1, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors. About Cadre Headquartered in Jacksonville, Florida, Cadre is

    7/22/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Reports First Quarter 2025 Financial Results

    Capitalizes on Continued Strong Demand for Mission Critical Safety Equipment Completes Acquisition of Multiple Leading Nuclear Brands, Expanding Geographic Footprint Increased Guidance Reflects Completed Acquisition and Reaffirmed Organic Growth Expectations 2025 Outlook: Net Sales of $618 to $648 Million and Adjusted EBITDA of $112 to $122 Million Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three months ended March 31, 2025. Net sales of $130.

    5/6/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Announces First Quarter 2025 Earnings and Conference Call Information

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the first quarter that ended on March 31, 2025, on Tuesday, May 6, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, May 7, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To participate in

    4/23/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Declares Quarterly Dividend of $0.095 Per Share

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on May 16, 2025 to shareholders of record as of the close of business on the record date of May 2, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors. About Cadre Headquartered in Jacksonville, Florida, Cadre is a globa

    4/22/25 4:16:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Completes Acquisition of Carr's Engineering Division

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, has completed the Company's previously announced acquisition of Carr's Engineering Limited (excluding Chirton Engineering) and Carr's Engineering (US), Inc. (together the "Engineering Division"), each a subsidiary of Carr's Group plc. The Engineering Division is comprised of industry-leading brands including Wälischmiller GmbH, CarrsMSM, Bendalls Engineering, NW Total Engineered Solutions, and NuVision Engineering, Inc. The enterprise value for the acquisition

    4/22/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Reports Fourth Quarter and Full Year 2024 Financial Results

    Achieved Annual Net Sales of $568 Million, Gross Margin of 41.1% and Net Income of $36 Million Generated Record Annual Adjusted EBITDA and Adjusted EBITDA Margin for Second Consecutive Year Expects Full Year 2025 Net Sales of $572 to $601 Million and Adjusted EBITDA of $105 to $115 Million Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the quarter and year ended December 31, 2024. Net sales of $176.0 million for the fourth quarter; net sales of $567.6

    3/11/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings to Announce Fourth Quarter and Full Year 2024 Earnings and 2025 Financial Guidance on March 11, 2025

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the fourth quarter that ended on December 31, 2024, on Tuesday, March 11, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results, as well as its 2025 financial guidance, on Wednesday, March 12, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine

    2/26/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Increases Dividend

    Declares Quarterly Dividend of $0.095 Per Share; ~9% Increase on Annualized Basis Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis, on the Company's common stock. On an annualized basis, the newly declared cash dividend represents an increase of 3 cents, or approximately 9%, over the previous annualized dividend of $0.35 per share. Cadre's dividend payment will be

    1/21/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Inc. SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Cadre Holdings Inc.

    SCHEDULE 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    8/12/25 4:16:56 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Cadre Holdings Inc.

    SCHEDULE 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    8/6/25 11:56:23 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form 10-Q filed by Cadre Holdings Inc.

    10-Q - Cadre Holdings, Inc. (0001860543) (Filer)

    8/5/25 4:16:50 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Cadre Holdings, Inc. (0001860543) (Filer)

    8/5/25 4:15:22 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form S-8 filed by Cadre Holdings Inc.

    S-8 - Cadre Holdings, Inc. (0001860543) (Filer)

    6/13/25 4:18:37 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - Cadre Holdings, Inc. (0001860543) (Filer)

    6/5/25 4:47:57 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SD filed by Cadre Holdings Inc.

    SD - Cadre Holdings, Inc. (0001860543) (Filer)

    5/30/25 4:06:20 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form 144 filed by Cadre Holdings Inc.

    144 - Cadre Holdings, Inc. (0001860543) (Subject)

    5/20/25 4:33:38 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SCHEDULE 13G filed by Cadre Holdings Inc.

    SCHEDULE 13G - Cadre Holdings, Inc. (0001860543) (Subject)

    5/13/25 6:03:15 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Cadre Holdings Inc.

    SCHEDULE 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    5/12/25 10:28:12 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO AND CHAIRMAN Kanders Warren B sold $819,500 worth of shares (25,000 units at $32.78) (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    6/24/25 4:35:50 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    CEO AND CHAIRMAN Kanders Warren B sold $3,348,000 worth of shares (100,000 units at $33.48) (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    6/23/25 4:15:18 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    CEO AND CHAIRMAN Kanders Warren B sold $4,200,750 worth of shares (125,000 units at $33.61) (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    6/5/25 4:15:25 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form 4 filed by Director Decotis Deborah A

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    6/3/25 4:49:53 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form 4 filed by Director Delzanno Gianmaria C

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    6/3/25 4:48:16 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form 4 filed by Director Quigley William G Iii

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    6/3/25 4:46:13 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form 4 filed by Director Norton Hamish

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    6/3/25 4:44:49 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    CEO AND CHAIRMAN Kanders Warren B sold $1,637,500 worth of shares (50,000 units at $32.75) (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    6/3/25 4:15:09 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    CEO AND CHAIRMAN Kanders Warren B sold $3,290,500 worth of shares (100,000 units at $32.91) (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    5/29/25 4:15:14 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    CEO AND CHAIRMAN Kanders Warren B sold $3,292,000 worth of shares (100,000 units at $32.92) (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    5/27/25 4:15:29 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cadre Holdings downgraded by BofA Securities with a new price target

    BofA Securities downgraded Cadre Holdings from Neutral to Underperform and set a new price target of $26.00

    8/13/25 8:01:40 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings downgraded by BofA Securities with a new price target

    BofA Securities downgraded Cadre Holdings from Buy to Neutral and set a new price target of $38.00

    6/13/25 7:45:51 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    ROTH MKM reiterated coverage on Cadre Holdings with a new price target

    ROTH MKM reiterated coverage of Cadre Holdings with a rating of Buy and set a new price target of $38.00 from $32.00 previously

    2/21/24 9:51:23 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings downgraded by Raymond James

    Raymond James downgraded Cadre Holdings from Outperform to Mkt Perform

    1/22/24 7:15:32 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    BofA Securities initiated coverage on Cadre Holdings with a new price target

    BofA Securities initiated coverage of Cadre Holdings with a rating of Buy and set a new price target of $30.00

    9/6/22 7:24:20 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Jefferies initiated coverage on Cadre Holdings with a new price target

    Jefferies initiated coverage of Cadre Holdings with a rating of Buy and set a new price target of $32.00

    8/31/22 9:04:21 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Raymond James reiterated coverage on Cadre Hldgs with a new price target

    Raymond James reiterated coverage of Cadre Hldgs with a rating of Outperform and set a new price target of $27.00 from $25.00 previously

    3/11/22 7:20:04 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Lake Street initiated coverage on Cadre Holdings with a new price target

    Lake Street initiated coverage of Cadre Holdings with a rating of Buy and set a new price target of $24.00

    11/29/21 8:50:52 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Stephens initiated coverage on Cadre Holdings with a new price target

    Stephens initiated coverage of Cadre Holdings with a rating of Overweight and set a new price target of $23.00

    11/29/21 7:51:17 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Stifel initiated coverage on Cadre Hldgs with a new price target

    Stifel initiated coverage of Cadre Hldgs with a rating of Hold and set a new price target of $20.00

    11/29/21 7:34:19 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Inc. Financials

    Live finance-specific insights

    View All

    Cadre Holdings Reports Second Quarter 2025 Financial Results

    Increased Quarterly Net Sales 9% and Gross Profit 10% Year-Over-Year Continued Strong Demand Trends for Mission Critical Safety Equipment Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three and six months ended June 30, 2025. Net sales of $157.1 million for the second quarter; net sales of $287.2 million for the six months ended June 30, 2025. Gross profit margin of 40.9% for the second quarter; gross profit margin of 41.9% for the six months

    8/5/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Announces Second Quarter 2025 Earnings and Conference Call Information

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the second quarter that ended on June 30, 2025, on Tuesday, August 5, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, August 6, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To partici

    7/23/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Declares Quarterly Dividend of $0.095 Per Share

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on August 15, 2025 to shareholders of record as of the close of business on the record date of August 1, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors. About Cadre Headquartered in Jacksonville, Florida, Cadre is

    7/22/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Reports First Quarter 2025 Financial Results

    Capitalizes on Continued Strong Demand for Mission Critical Safety Equipment Completes Acquisition of Multiple Leading Nuclear Brands, Expanding Geographic Footprint Increased Guidance Reflects Completed Acquisition and Reaffirmed Organic Growth Expectations 2025 Outlook: Net Sales of $618 to $648 Million and Adjusted EBITDA of $112 to $122 Million Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three months ended March 31, 2025. Net sales of $130.

    5/6/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Announces First Quarter 2025 Earnings and Conference Call Information

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the first quarter that ended on March 31, 2025, on Tuesday, May 6, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, May 7, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To participate in

    4/23/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Declares Quarterly Dividend of $0.095 Per Share

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on May 16, 2025 to shareholders of record as of the close of business on the record date of May 2, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors. About Cadre Headquartered in Jacksonville, Florida, Cadre is a globa

    4/22/25 4:16:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Completes Acquisition of Carr's Engineering Division

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, has completed the Company's previously announced acquisition of Carr's Engineering Limited (excluding Chirton Engineering) and Carr's Engineering (US), Inc. (together the "Engineering Division"), each a subsidiary of Carr's Group plc. The Engineering Division is comprised of industry-leading brands including Wälischmiller GmbH, CarrsMSM, Bendalls Engineering, NW Total Engineered Solutions, and NuVision Engineering, Inc. The enterprise value for the acquisition

    4/22/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Reports Fourth Quarter and Full Year 2024 Financial Results

    Achieved Annual Net Sales of $568 Million, Gross Margin of 41.1% and Net Income of $36 Million Generated Record Annual Adjusted EBITDA and Adjusted EBITDA Margin for Second Consecutive Year Expects Full Year 2025 Net Sales of $572 to $601 Million and Adjusted EBITDA of $105 to $115 Million Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the quarter and year ended December 31, 2024. Net sales of $176.0 million for the fourth quarter; net sales of $567.6

    3/11/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings to Announce Fourth Quarter and Full Year 2024 Earnings and 2025 Financial Guidance on March 11, 2025

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the fourth quarter that ended on December 31, 2024, on Tuesday, March 11, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results, as well as its 2025 financial guidance, on Wednesday, March 12, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine

    2/26/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Increases Dividend

    Declares Quarterly Dividend of $0.095 Per Share; ~9% Increase on Annualized Basis Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis, on the Company's common stock. On an annualized basis, the newly declared cash dividend represents an increase of 3 cents, or approximately 9%, over the previous annualized dividend of $0.35 per share. Cadre's dividend payment will be

    1/21/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Inc. Leadership Updates

    Live Leadership Updates

    View All

    Cadre Holdings Appoints Gianmaria Delzanno to its Board of Directors

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced the appointment of Gianmaria Delzanno to its board of directors, effective as of January 13, 2025. Current Director Nicholas Sokolow, who joined the board of Cadre's predecessor in July of 2012, will retire from the Company's board, effective as of January 31, 2025. Upon Mr. Sokolow's departure, Mr. Delzanno will replace Mr. Sokolow as the lead independent director and will also serve as Chairman of the Nominating and Corporate Governance Committee as

    1/13/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Appoints Deborah DeCotis to its Board of Directors

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced the appointment of Deborah DeCotis to its board of directors, effective immediately. With Ms. DeCotis' appointment, the Board will expand to five directors, four of whom are independent. Ms. DeCotis will also serve on the Company's Compensation Committee. Ms. DeCotis has over 45 years of financial, advisory and business operations experience with a successful track record of leadership across multiple global institutions and industries. She currently serves as Advisory Director at Morgan Stanley & Co., Inc.

    4/12/22 8:30:00 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    ElectraMeccanica Appoints Automotive Veteran, William Quigley III, to Board of Directors

    VANCOUVER, British Columbia, April 07, 2022 (GLOBE NEWSWIRE) -- ElectraMeccanica Vehicles Corp. (NASDAQ:SOLO) ("ElectraMeccanica" or the "Company"), a designer and manufacturer of electric vehicles revolutionizing the urban driving experience, today announced the appointment of William (Bill) Quigley III to its Board of Directors. Mr. Quigley is an accomplished leader with a proven track record in large enterprises specific to the automotive industry. With 30 plus years in the industry, Bill's career has included the following key roles: Executive Vice President and Chief Financial Officer at Dana Holding Corporation, an automotive, commercial vehicle and off-highway driveline, sealing an

    4/7/22 8:05:00 AM ET
    $CDRE
    $SOLO
    Industrial Specialties
    Health Care
    Auto Manufacturing
    Consumer Discretionary

    Cadre Holdings Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cadre Holdings Inc.

    SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    11/12/24 9:50:14 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G filed by Cadre Holdings Inc.

    SC 13G - Cadre Holdings, Inc. (0001860543) (Subject)

    2/14/24 7:58:49 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Cadre Holdings Inc. (Amendment)

    SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    2/12/24 4:15:31 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Cadre Holdings Inc. (Amendment)

    SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    2/9/24 8:50:19 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Cadre Holdings Inc. (Amendment)

    SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    6/12/23 8:21:19 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Cadre Holdings Inc. (Amendment)

    SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    2/14/23 4:18:17 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Cadre Holdings Inc. (Amendment)

    SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    2/14/23 4:06:46 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G filed by Cadre Holdings Inc.

    SC 13G - Cadre Holdings, Inc. (0001860543) (Subject)

    2/9/23 9:59:40 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G filed by Cadre Holdings Inc.

    SC 13G - Cadre Holdings, Inc. (0001860543) (Subject)

    2/14/22 5:12:28 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G filed by Cadre Holdings Inc.

    SC 13G - Cadre Holdings, Inc. (0001860543) (Subject)

    2/14/22 4:16:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care